Coming of age: emerging health preference research based on established scientific standards

10 August 2020 - Value in Health themed section enhances the scientific respectability and relevance of health preference research. ...

Read more →

Australian start-ups push for bigger role in vaccine making

9 August 2020 - An Australian startup racing to develop a successful coronavirus vaccine has urged the federal government to ...

Read more →

Italy becomes first country to require pharma to disclose public funding for R&D costs

6 August 2020 - Amid growing clamour for more transparency from the pharmaceutical industry, Italy has become the first country ...

Read more →

The world is spending nowhere near enough on a coronavirus vaccine

6 August 2020 - Far better to spend far too much. ...

Read more →

Scientific research on the coronavirus is being released in a torrent

6 May 2020 - Will that change how science is published? ...

Read more →

Greg Hunt: Australia now leading the race for a vaccine

16 April 2020 - Australia has long punched above its weight in health and medical research — think Gardasil, cochlear and ...

Read more →

Scientists rush to find coronavirus cure—but it still isn’t fast enough

6 April 2020 - For drug companies, there is suddenly only one priority: the coronavirus. ...

Read more →

Preserving clinical trial integrity during the coronavirus pandemic

25 March 2020 - Randomised clinical trials provide the highest-quality evidence for identifying therapies to help people attain longer and healthier ...

Read more →

Treating COVID-19—off-label drug use, compassionate use, and randomised clinical trials during pandemics

24 March 2020 - In the 2014 Ebola outbreak, close to 30 000 individuals developed Ebola viral disease, and numerous therapies were ...

Read more →

FDA touts generic drug research in 2019

19 February 2020 - The US FDA on Tuesday released a report detailing the scientific research carried out and funded ...

Read more →

Incidental imaging findings in clinical trials

13 January 2020 - Clinical trial end points are outcome measures used to assess the efficacy and safety of an ...

Read more →

Proposed changes to research and development tax incentive will discourage investment and undermine innovation

6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...

Read more →

The real impact of drug price legislation on biopharmaceutical R&D

2 October 2019 - As outcry around drug prices rages, arguments continue to surface that limiting corporate revenues via price controls ...

Read more →

Progressing the long-term plan for stem cell research

2 October 2019 - This is the next step in the $150 million Stem Cell Therapies Mission, helping world-class Australian researchers ...

Read more →

Clinical trials to combat reproductive cancers

9 September 2019 - The Australian Government is investing up to $15 million in targeted clinical trials to improve treatments and ...

Read more →